| Trial ID: | L7243 |
| Source ID: | NCT01954147
|
| Associated Drug: |
Glp-1
|
| Title: |
Umbilical Cord Mesenchymal Stem Cells and Liraglutide in Diabetes Mellitus
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: GLP-1|BIOLOGICAL: SC|OTHER: Standard Medical Treatment
|
| Outcome Measures: |
Primary: HbA1C, 1 year | Secondary: Fasting Blood Glucose, 1 year
|
| Sponsor/Collaborators: |
Sponsor: Diabetes Care Center of Nanjing Military Command
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1|PHASE2
|
| Enrollment: |
100
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: FACTORIAL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2013-10
|
| Completion Date: |
2015-10
|
| Results First Posted: |
|
| Last Update Posted: |
2014-02-20
|
| Locations: |
Diabetes Care Center of Nanjing Military Command, Fuzhou, Fujian, 350025, China
|
| URL: |
https://clinicaltrials.gov/show/NCT01954147
|
